RE: Share price9 May 2023 16:23
I too am a LTH.
I genuinely feel that the SP is well below expectations, but there are many ways that this can be and IMO is restricted by the MM.
Just my assumption and only based on Comms and research I think that we are getting closer to a major inflection point.
This may take place when efficacy is known from p1b.
This is further derisking.
Furthermore I do agree somewhat with people that have queried financials, but this to me relates to actually showing that the concept of 6000 is a per pre clinical trials.
Some people keep saying that we must be asking revenue and I disagree. If the process works and is proved then getting to market whether going alone, with other or bought out is then inevitable is some way shape or form.
Just my thoughts.